3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hepatitis B
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
Amifostine
19
Cisplatin
15
Radiotherapy
13
Etoposide
10
Cyclophosphamide
9
Carboplatin
8
Paclitaxel
7
Filgrastim
7
Drug Therapy
5
Cytarabine
5
apatinib
4
sodium thiosulfate
3
Methylprednisolone
3
Methotrexate
3
Gemcitabine
3
Docetaxel
3
sargramostim
2
pegfilgrastim
2
etoposide phosphate
2
camrelizumab
2
Vincristine
2
Pyridoxine
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Mitoxantrone
2
Melphalan
2
Irinotecan
2
Ifosfamide
2
Fibroblast Growth Factor 7
2
Epoetin Alfa
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Drug-Related Side Effects and Adverse Reactions
×
Telbivudine
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled